Fevertree - FEVR on LSE - Mcap £1.1bn @ 900p - Premium soft drinks (mostly for mixing) - stock down 25% on revised EBITDA guidance today due to cost inflation (claimed transitory). If they can get EBITDA back to c£80m in next few years you are buying at c12x EBITDA for a high quality biz w/ decent remaining growth trajectory (Diageo and Coca-Cola c24x).…
Substack is the home for great culture


